Nanoparticle-Mediated Targeting of the Fusion Gene RUNX1/ETO in t(8; 21)-Positive Acute Myeloid Leukemia

Scientists described the use of siRNA-loaded lipid nanoparticles for the specific therapeutic targeting of the leukemic fusion gene RUNX1/ETO.